COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean

Virtual Health Sciences Library

  • Home
  • Search
  • Knowledge Base
  • Get a journal indexed in the Index Medicus
  • MyVHSL
  1. Home
  2. IMEMR
  3. Search Result
  4. Tinea pseudomibricata due to Trichophyton mentagrophytes: a rare case report

Tinea pseudomibricata due to Trichophyton mentagrophytes: a rare case report

Authors

Kumar Sumir
Kamra, Nidhi
Mahajan, Bharat Bhushan
GGS Medical College and Hospital ; ,

Iran. J. Endocrinol. Metab. 2015; 25 (2): 151-153
JPAD-Journal of Pakistan Association of Dermatologists
Journal Country: Pakistan
P-ISSN: 1560-9014
E-ISSN: 2413-7650
Type of Publication: Case Reports
Category: Humans, Infant,
Type of Research: Clinical
Keywords: Tinea / Diagnosis
Broad Subjects: Maternal, Reproductive and Child Health, Trichophyton ,Imidazoles ,Thiophenes
Citation: Sumir Kumar ,Nidhi Kamra ,Bharat Bhushan Mahajan , Tinea pseudomibricata due to Trichophyton mentagrophytes: a rare case report, Iran. J. Endocrinol. Metab. 2015; 25 (2): 151-153

Abstract English

Tinea pseudoimbricata is characterized by concentric scaly rings simulating tinea imbricata but caused by dermatophytes other than Trichophyton concentricum. We report a unique case of tinea pseudomibricata, its pathogenesis and review of previously reported cases. A 1.5-year-old baby developed concentric rings of scaly lesions over groins and buttocks following use of topical corticosteroids for 1 month. Mycological studies were performed to establish the diagnosis. Diagnosis of tinea pseudoimbricata was made on the basis of morphology of lesions and was confirmed by isolation of T. mentagrophytes on culture. Complete clinical and mycological cure was obtained with topical 1% sertaconazole given for 4weeks

Full Text English
3 Downloads

Subscribe to VHSL Newsletters

© 2020 WHO – EMRO